MA pushes transparency
July 7, 2015
Medicines Australia (MA) has
launched an awareness campaign
to ensure healthcare professionals
are aware of and understand
the effects of new transparency
enhancements contained in the
updated 18th Edition Code of
Conduct.
The new arrangements come into
play 01 Oct forcing all exchanges of
value to healthcare professionals
from industry to be disclosed online
and made available to the public.
Educational material explaining
the rules will be provided to
healthcare professionals’ member
organisations, colleges and other
stakeholders.
MA ceo Tim James said, “Our
members are proud of the work
that we do to ensure that the public
can continue to have confidence in
our local medicines industry.
“Transparency is a key component
of the bond of trust with the
Australian public.
“A strong working relationship and
the ongoing exchange of knowledge
between the medicine makers and
healthcare professionals are critical
to better patient outcomes,” James
added.
He said expert advice from
experienced health professionals
is important to ensure vital new
medicines are developed and used
safely and effectively”.
Under the new code, MA member
companies are to report details
such as airfares, accommodation
and conference registration fees
when engaging a healthcare
professional for their service.
In such cases, the healthcare
professional will be asked to agree
to the reporting requirement
around any transfer of value for
the first 12 months, but from
01 Oct 2016, the reporting of
such arrangements will become
mandatory.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jul 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jul 15
